InterPharma loses bid to invalidate Pfizer’s Precedex patent
Intellectual Property June 24, 2019 11:54 am By Miklos Bolza | Sydney

Global pharmaceutical giant Pfizer has successfully defended the patent for its sedative drug Precedex against a validity challenge, a big win for the drug maker […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
related coverage